Neuehealth Stock Today

NEUE Stock   5.07  0.12  2.42%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 83

 
High
 
Low
Very High
NeueHealth is trading at 5.07 as of the 21st of November 2024, a 2.42 percent increase since the beginning of the trading day. The stock's lowest day price was 4.83. NeueHealth has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. NeueHealth symbol was changed from BHG on 29th of January 2024. Equity ratings for NeueHealth are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
24th of June 2021
Category
Healthcare
Classification
Health Care
NeueHealth is entity of United States. It is traded as Stock on NYSE exchange. The company has 8.22 M outstanding shares of which 42.2 K shares are now shorted by private and institutional investors with about 4.22 trading days to cover. More on NeueHealth

Moving against NeueHealth Stock

  0.68LH LaboratoryPairCorr
  0.55GH Guardant HealthPairCorr
  0.43VVOS Vivos TherapeuticsPairCorr
  0.4EHAB EnhabitPairCorr
  0.38VREX Varex Imaging CorpPairCorr

NeueHealth Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Older SymbolBHG
CEO ChairmanGeorge III
Thematic IdeaInsurance (View all Themes)
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, Insurance, Health Care, Health Care Providers & Services, Healthcare Plans, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.990.9472
Sufficiently Up
Slightly volatile
Gross Profit Margin0.10.1415
Way Down
Very volatile
Total Current Liabilities1.8 B1.4 B
Significantly Up
Slightly volatile
Non Current Liabilities Total84.4 M88.8 M
Notably Down
Pretty Stable
Total Assets1.2 B1.2 B
Notably Down
Slightly volatile
Total Current Assets1.8 B1.1 B
Way Up
Slightly volatile
Debt Levels
NeueHealth can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand NeueHealth's financial leverage. It provides some insight into what part of NeueHealth's total assets is financed by creditors.
Liquidity
NeueHealth currently holds 370.35 M in liabilities. Note, when we think about NeueHealth's use of debt, we should always consider it together with its cash and equity.

Stock Based Compensation

59.21 Million
NeueHealth (NEUE) is traded on New York Stock Exchange in USA. It is located in 9250 NW 36th St, Doral, FL, United States, 33178 and employs 1,252 people. NeueHealth was previously known as Bright Health Group and was traded on New York Stock Exchange under the symbol BHG. NeueHealth is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 52.8 M. NeueHealth conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 8.22 M outstanding shares of which 42.2 K shares are now shorted by private and institutional investors with about 4.22 trading days to cover. NeueHealth generates negative cash flow from operations
Check NeueHealth Probability Of Bankruptcy
Ownership Allocation
The market capitalization of NeueHealth is USD52.8 Million. Over half of NeueHealth's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check NeueHealth Ownership Details

NeueHealth Historical Income Statement

At present, NeueHealth's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 311.2 M, whereas Gross Profit is forecasted to decline to about 130.4 M. View More Fundamentals

NeueHealth Stock Against Markets

NeueHealth Corporate Management

Jeff CraigGeneral SecretaryProfile
Jeffrey SchermanChief OfficerProfile
Jay MatushakChief OfficerProfile
Tomas OrozcoExecutive CareProfile
When determining whether NeueHealth is a strong investment it is important to analyze NeueHealth's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NeueHealth's future performance. For an informed investment choice regarding NeueHealth Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeueHealth. If investors know NeueHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeueHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
145.939
Quarterly Revenue Growth
0.286
Return On Assets
(0.04)
Return On Equity
(1.83)
The market value of NeueHealth is measured differently than its book value, which is the value of NeueHealth that is recorded on the company's balance sheet. Investors also form their own opinion of NeueHealth's value that differs from its market value or its book value, called intrinsic value, which is NeueHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeueHealth's market value can be influenced by many factors that don't directly affect NeueHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeueHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeueHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeueHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.